Medical Disposables & Supplies Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kurt Boothe

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	4yrs
Eigendom CEO	19.4%
Management gemiddelde ambtstermijn	4.1yrs
Gemiddelde ambtstermijn bestuur	10.9yrs

Recente managementupdates

Recent updates

CEO

Kurt Boothe

4yrs

Tenure

Mr. Kurt Boothe was a Company Secretary and General Manager of Medical Disposables & Supplies Limited until November 01, 2020 and serves as Executive Director. He serves as Chief Executive Officer of Medic...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kurt Boothe	CEO & Executive Director	4yrs	geen gegevens	19.44% JMD 88.0m
Myrtis Boothe	Founder & Executive Director	no data	geen gegevens	19% JMD 86.0m
Raymond Ernandez	Chief Financial Officer	no data	geen gegevens	geen gegevens
Bertino Gordon	Operations Manager	4.7yrs	geen gegevens	geen gegevens
Nadine Banton	Human Resource & Administrative Manager	4.1yrs	geen gegevens	geen gegevens
Kandise Morgan-Small	Sales & Marketing Manager	no data	geen gegevens	geen gegevens
Nikeisha Hill	Executive Director	no data	geen gegevens	19% JMD 86.0m

4.1yrs

Gemiddelde duur

Ervaren management: Het managementteam van MDS wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kurt Boothe	CEO & Executive Director	no data	geen gegevens	19.44% JMD 88.0m
Myrtis Boothe	Founder & Executive Director	no data	geen gegevens	19% JMD 86.0m
Nikeisha Hill	Executive Director	no data	geen gegevens	19% JMD 86.0m
Vincent Lawrence	Lead Independent Director	10.9yrs	JA$613.75k	geen gegevens
Sheree Martin	Director	less than a year	geen gegevens	geen gegevens
Winston Boothe	Chairman	no data	JA$713.75k	19% JMD 86.0m
Dahlia McDaniel-Dickson	Independent Non-Executive Director	10.9yrs	JA$643.75k	0.55% JMD 2.5m

10.9yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MDS zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.9 jaar).

Medical Disposables & Supplies Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Medical Disposables & Supplies Limited Announces Board Appointments

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Second quarter 2025 earnings released: JA$0.16 loss per share (vs JA$0.10 loss in 2Q 2024)

Medical Disposables & Supplies Limited to Report Fiscal Year 2024 Final Results on Nov 29, 2024

Medical Disposables & Supplies Limited Announces Board Appointments

Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023)

New minor risk - Share price stability

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

New major risk - Share price stability

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

Investor sentiment deteriorates as stock falls 24%

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Investor sentiment improves as stock rises 22%

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Upcoming dividend of JA$0.09 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JA$0.07 per share

First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021)

Full year 2021 earnings released

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: JA$4.74

Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020)

Second quarter 2021 earnings released: JA$0.02 loss per share

Market pulls back on stock over the past week

New 90-day low: JA$4.30

New 90-day low - JA$4.67

First quarter earnings released

New 90-day low - JA$5.07

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur